Literature DB >> 2737955

Biological properties of streptonigrin derivatives. III. In vitro and in vivo antiviral and antitumor activities.

Y Take1, T Kubo, E Takemori, Y Inouye, S Nakamura, T Nishimura, H Suzuki, H Yamaguchi.   

Abstract

Antitumor antibiotic streptonigrin (STN-COOH) is a potent inhibitor of avian myeloblastosis virus (AMV) and human immunodeficiency virus reverse transcriptases. The carboxyl group at 2'-position of STN-COOH was modified to give esters, hydrazide, amides and amino acid derivatives for biological studies. Against AMV reverse transcriptase, the hydrazide, amides and amino acid derivatives showed inhibitory activity, which compared favorably to that of STN-COOH, with the ID50 values ranging 2-8 micrograms/ml. In contrast, the esters lacked this activity except for those having a dimethylamino group in the substituent. Splenomegaly caused by Friend leukemia virus infection was significantly inhibited by STN-COOH and STN-COO(CH2)3N(CH3)2, but not STN-CONH(CH2)3N(CH3)2. Doxorubicin-resistant murine lymphoblastoma L5178Y cells showed collateral sensitivity to both STN-COOH and STN-COO(CH2)3N(CH3)2 not only in vitro but also in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737955     DOI: 10.7164/antibiotics.42.968

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  A rapid method for screening large numbers of environmental microorganisms for antiviral activity.

Authors:  C Maullu; G Lampis; D Deidda; S Petruzzelli; R Pompei
Journal:  Appl Environ Microbiol       Date:  1998-03       Impact factor: 4.792

2.  Total synthesis of the antitumor antibiotic (±)-streptonigrin: first- and second-generation routes for de novo pyridine formation using ring-closing metathesis.

Authors:  Timothy J Donohoe; Christopher R Jones; Anne F Kornahrens; Luiz C A Barbosa; Louise J Walport; Matthew R Tatton; Michael O'Hagan; Akshat H Rathi; David B Baker
Journal:  J Org Chem       Date:  2013-12-12       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.